BIORA THERAPEUTICS, INC.
DelistedCIK 1580063fmd_0DH46BEWR8749EYZVYKBBJGCBZManufacturing · Pharmaceutical PreparationsTemplate: Standard
Coverage: Jan 01, 2019 to Sep 30, 2024, 23 periods
Latest annual · FY2023
Millions- Total revenues
- 0
- Gross profit
- 1
- Operating income
- (67)
- Net income
- (124)
- Free cash flow
- (49)
Latest quarter · Q3 FY2024
Millions- Total revenues
- 0
- Operating income
- (16)
- Net income
- (18)
- Free cash flow
- (9)
Key stats
Open AnalysisCompound annual growth
- Revenue, 3 yearsFY2020 to FY2023
- -96.2%
BIORA THERAPEUTICS, INC. financials: quick answers
Annual figures as filed with the SEC. Each number links to the filing it came from and to its proof.
| Metric | FY2023 | FY2022 | Change | Source |
|---|---|---|---|---|
| Revenue | $4,000 | $12.2 million | -100% | 10-K 2024-04-01 · proof |
| Operating income | -$67.1 million | -$61.8 million | 10-K 2024-04-01 · proof | |
| Net income | -$124.1 million | -$38.2 million | 10-K 2024-04-01 · proof | |
| Cash from operating activities | -$48.5 million | -$64.4 million | 10-K 2024-04-01 · proof | |
| Free cash flow | -$48.6 million | -$65.2 million | 10-K 2024-04-01 · proof | |
| Total assets | $31.2 million | $53.5 million | -41.7% | 10-K 2024-04-01 · proof |
| Total liabilities | $132.6 million | $155.8 million | -14.9% | 10-K 2024-04-01 · proof |
| Cash and cash equivalents | $15 million | $30.5 million | -50.8% | 10-K 2024-04-01 · proof |
- What was BIORA THERAPEUTICS, INC.'s revenue in fiscal 2023?
- BIORA THERAPEUTICS, INC. reported revenue of $4,000 for fiscal 2023 (the year ended Dec 31, 2023), against $12.2 million the year before (-100%). Source: the 10-K filed with the SEC on Apr 1, 2024. SEC
- What was BIORA THERAPEUTICS, INC.'s operating income in fiscal 2023?
- BIORA THERAPEUTICS, INC. reported operating income of -$67.1 million for fiscal 2023 (the year ended Dec 31, 2023), against -$61.8 million the year before. Source: the 10-K filed with the SEC on Apr 1, 2024. SEC
- What was BIORA THERAPEUTICS, INC.'s net income in fiscal 2023?
- BIORA THERAPEUTICS, INC. reported net income of -$124.1 million for fiscal 2023 (the year ended Dec 31, 2023), against -$38.2 million the year before. Source: the 10-K filed with the SEC on Apr 1, 2024. SEC
- What was BIORA THERAPEUTICS, INC.'s cash from operating activities in fiscal 2023?
- BIORA THERAPEUTICS, INC. reported cash from operating activities of -$48.5 million for fiscal 2023 (the year ended Dec 31, 2023), against -$64.4 million the year before. Source: the 10-K filed with the SEC on Apr 1, 2024. SEC
- What was BIORA THERAPEUTICS, INC.'s free cash flow in fiscal 2023?
- BIORA THERAPEUTICS, INC. reported free cash flow of -$48.6 million for fiscal 2023 (the year ended Dec 31, 2023), against -$65.2 million the year before. Source: the 10-K filed with the SEC on Apr 1, 2024. SEC
- What are BIORA THERAPEUTICS, INC.'s total assets?
- As of Dec 31, 2023, BIORA THERAPEUTICS, INC. reported total assets of $31.2 million, against $53.5 million a year earlier (-41.7%). Source: the 10-K filed with the SEC on Apr 1, 2024. SEC
- What are BIORA THERAPEUTICS, INC.'s total liabilities?
- As of Dec 31, 2023, BIORA THERAPEUTICS, INC. reported total liabilities of $132.6 million, against $155.8 million a year earlier (-14.9%). Source: the 10-K filed with the SEC on Apr 1, 2024. SEC
- What are BIORA THERAPEUTICS, INC.'s cash and cash equivalents?
- As of Dec 31, 2023, BIORA THERAPEUTICS, INC. reported cash and cash equivalents of $15 million, against $30.5 million a year earlier (-50.8%). Source: the 10-K filed with the SEC on Apr 1, 2024. SEC
Read from the FinancialMD API on Nov 13, 2026. Values change only when a new filing is made; see the Financials tab for every period and as-of replay.
The same numbers for an agent, with proof on every value:
curl "https://api.financial.md/v1/company/financials/income_statement/standardized?company=cik:1580063&period_type=annual&limit=5"Information only, not investment advice.